A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma
β Scribed by E. Nagura; Atsushi Ichikawa; Osamu Kamiya; Ryoichi Kato; Makoto Utsumi; Masao Tanaka; Hideo Takeyama; Kazuyuki Shimizu; Masahide Kobayashi; Kazuyuki Naito; Hiroshi Nishiwaki; Harumitsu Mizuno; Noriyuki Hirabayashi; Masakazu Nitta; Yasuharu Kato; Toshihiko Shibata; Tomomitsu Hotta; Kohei Kawashima; Hidehiko Saito
- Book ID
- 105994146
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 145 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A review of the clinical studies in which interferons have been involved has shown that they may have a role in the treatment of multiple myeloma. Twelve studies, each of which involved at least 10 evaluable cases (352 in total) with various dose schedules involving leukocyte, lymphoblastoid and rec
Fifty-two patients with progressive resistant multiple myeloma were entered in this Southwest Oncology Group Phase II study, using weekly intravenous Aclacinomycin A. Of forty-three evaluable patients for response, there was one partial remission of 2 years duration and two sustained clinical improv